NP

Nishat Perween Intikhab Ansari

Active Director Director DIN 10883828
DIN 10883828 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nishat Perween Intikhab Ansari

Data last updated:

Nishat Perween Intikhab Ansari is a Director at Meditrue Lifesciences Private Limited (since 2024). The company operates in Paper.

DIN 10883828
Primary Designation Director
Industry Paper
First Appointment 21 Dec 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Dec 20242023Active

Board colleagues of Nishat Perween Intikhab Ansari

Directorship timeline

Open interactive timeline →
Meditrue Lifesciences Private Limited
Premium access

Shareholding and investment profile for Nishat Perween Intikhab Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishat Perween Intikhab Ansari

Nishat Perween Intikhab Ansari currently holds 1 directorship: Meditrue Lifesciences Private Limited (Director, since 21 Dec 2024).

Nishat Perween Intikhab Ansari was first appointed on 21 Dec 2024 as Director at Meditrue Lifesciences Private Limited.

The current boards of Nishat Perween Intikhab Ansari's companies include Afshin Zulfiqar Ali Khan (Meditrue Lifesciences Private Limited), Faiyyaz Ahmed Riyaz Ahmad (Meditrue Lifesciences Private Limited), Sayyad Arbaaz Ali (Meditrue Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available